Nuwellis (NUWE) Revenue (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.87% |
| Dec 31, 2025 | 9.34% |
| Sep 30, 2025 | 28.52% |
| Jun 30, 2025 | -9.40% |
| Mar 31, 2025 | -18.00% |
| Dec 31, 2024 | -1.90% |
| Sep 30, 2024 | 7.89% |
| Jun 30, 2024 | 18.15% |
| Mar 31, 2024 | -27.21% |
| Dec 31, 2023 | 5.76% |
| Sep 30, 2023 | 16.24% |
| Jun 30, 2023 | 13.64% |
| Mar 31, 2023 | -21.93% |
| Dec 31, 2022 | 13.27% |
| Sep 30, 2022 | -6.69% |
| Jun 30, 2022 | 14.90% |
| Mar 31, 2022 | 17.30% |
| Dec 31, 2021 | -11.39% |
| Sep 30, 2021 | -26.12% |
| Jun 30, 2021 | 30.76% |
| Mar 31, 2021 | -6.16% |
| Dec 31, 2020 | 7.35% |
| Sep 30, 2020 | 2.20% |
| Jun 30, 2020 | 14.29% |
| Mar 31, 2020 | 19.24% |
| Dec 31, 2019 | 9.19% |
| Sep 30, 2019 | -25.34% |
| Jun 30, 2019 | 38.02% |
| Mar 31, 2019 | -18.95% |
| Dec 31, 2018 | 9.98% |
| Sep 30, 2018 | 24.02% |
| Jun 30, 2018 | 5.98% |
| Mar 31, 2018 | 24.79% |
| Dec 31, 2017 | -13.17% |
| Sep 30, 2017 | 10.76% |
| Jun 30, 2017 | -4.11% |
| Mar 31, 2017 | 20.78% |
| Dec 31, 2016 | 37.38% |
| Mar 31, 2015 | -66.67% |
| Dec 31, 2014 | 200.00% |